These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34311024)

  • 21. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines.
    Alshetaili AS
    Saudi J Biol Sci; 2021 Sep; 28(9):5065-5073. PubMed ID: 34466084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
    Gao H; Zhang Q; Yang Y; Jiang X; He Q
    Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer.
    Han W; Shi L; Ren L; Zhou L; Li T; Qiao Y; Wang H
    Signal Transduct Target Ther; 2018; 3():16. PubMed ID: 29942660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.
    Godugu C; Doddapaneni R; Patel AR; Singh R; Mercer R; Singh M
    Pharm Res; 2016 Jan; 33(1):137-54. PubMed ID: 26286185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and
    Amin H; Osman SK; Mohammed AM; Zayed G
    Saudi Pharm J; 2023 Jan; 31(1):29-54. PubMed ID: 36685309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles.
    Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N
    Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.
    Chang TH; Tsai MF; Su KY; Wu SG; Huang CP; Yu SL; Yu YL; Lan CC; Yang CH; Lin SB; Wu CP; Shih JY; Yang PC
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1071-9. PubMed ID: 21037017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer.
    Yuan R; Huang Y; Chan L; He D; Chen T
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45714-45727. PubMed ID: 32927941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and Design of a Randomized Phase 2 Trial of Gefitinib Plus Bevacizumab vs Gefitinib Alone in Patients with Epidermal Growth Factor Receptor Mutant Non-Squamous Non-Small-Cell Lung Cancer: Study Protocol.
    Kitagawa C; Kada A; Saito AM; Ichinose Y; Saka H
    Kurume Med J; 2019 May; 65(2):77-81. PubMed ID: 30429415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemo-photodynamic therapy by pulmonary delivery of gefitinib nanoparticles and 5-aminolevulinic acid for treatment of primary lung cancer of rats.
    Zhang T; Bao J; Zhang M; Ge Y; Wei J; Li Y; Wang W; Li M; Jin Y
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101807. PubMed ID: 32404298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Experiments (DoE) Approach to Optimize the Sustained Release Microparticles of Gefitinib.
    Soni G; Yadav KS; Gupta MK
    Curr Drug Deliv; 2019; 16(4):364-374. PubMed ID: 30588883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots.
    Li X; Zhao Z; Yang Y; Liu Z; Wang J; Xu Y; Zhang Y
    J Mater Chem B; 2020 Mar; 8(11):2307-2320. PubMed ID: 32100786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling.
    Chen S; Ren Y; Duan P
    Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib.
    Huang MH; Lee JH; Chang YJ; Tsai HH; Lin YL; Lin AM; Yang JC
    Mol Oncol; 2013 Feb; 7(1):112-20. PubMed ID: 23102728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
    Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
    Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.